Rigaku introduces compact WDXRF analyzer for ultra-low sulfur (ULS) determination in fuels
July 1, 2013
Tokyo, Japan. Rigaku Corporation is pleased to announce the introduction of the Rigaku Micro-Z ULS sulfur analyzer. Designed for ultra-low level sulfur analysis of diesel and petrol (gasoline) fuels, this benchtop wavelength dispersive X-ray fluorescence (WDXRF) instrument features a novel design that measures both the sulfur peak and the background intensity. Rigaku Micro-Z ULS meets [...]
Seegene and Eidia Collaborate to Bring New Multiplex Molecular Diagnostic Tests to Japan
July 1, 2013
Gaithersburg, Maryland and Seoul, Korea, - Seegene Inc. (KOSDAQ: 096530), a leading developer of multiplexed molecular technologies and diagnostic tests, today announced that it has entered into a collaboration agreement with Eidia, the in vitro diagnostics subsidiary arm of Eisai Co., Ltd. (TYO: 4523), a world leader in pharmaceuticals headquartered in Japan. Through this agreement, [...]
July 1, 2013
INDIANAPOLIS, -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its U.S. Diagnostics unit was ranked number one in overall service performance by clinical laboratories in the 2013 ServiceTrak™ Clinical Report. The report was issued by IMV Ltd, an independent firm that produces an annual series of proprietary reports derived from extensive phone surveys [...]
Donation boosts research and learning outcomes
July 1, 2013
Griffith University’s School of Biomolecular and Physical Sciences has gratefully accepted the donation of a Waters Quattro Premier XE mass spectrometer for its new state of the art Chemistry Teaching Laboratory. Waters Australia General Manager Mr Peter Fuller said his company is proud of its relationship with Griffith and the School of BPS. “Partnering with [...]
PerkinElmer Introduces the Flexar™PDA Plus™Detector for Improved Chromatographic Information
July 1, 2013
With the Flexar™ PDA Plus™, the latest addition to the PerkinElmer Flexar liquid chromatography product family, scientists analyzing environmental, food, pharmaceutical and chemical samples can now better meet industry regulations and higher throughput demand. This innovative technology brings the flexibility of modular design, the power of sensitivity and accuracy and the fastest sampling speeds to [...]
July 1, 2013
REDWOOD CITY, Calif.-- Illumina, Inc. (NASDAQ: ILMN) today announced that Teva Pharmaceutical Industries Ltd. signed an exclusive agreement with Verinata Health, an Illumina company, for the commercialization of the verifi® non-invasive prenatal test1 in Israel. The MOR Institute for Medical Data Ltd., through its relationship with Teva, will provide the verifi® prenatal test to customers [...]
Implant Sciences Sells 11 Quantum Sniffers for Critical Infrastructure Protection to Saudi Arabia
July 1, 2013
WILMINGTON, MA -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has won a contract for 11 Quantum Sniffer™ QS-H150 handheld explosives trace detectors (ETDs) from a customer in Saudi Arabia. The units will be deployed for critical infrastructure protection in [...]
IDBS and Vivenics introduce novel SaaS approach for Netherlands science park
July 1, 2013
London, UK, Boston, US and Oss, Netherlands, - IDBS, the global provider of innovative data management, analytics and modeling solutions, today announced a partnership with informatics firm Vivenics, which offers solutions for life sciences research and development (R&D) organizations. Together the companies have introduced a novel Software-as-a-Service (SaaS) approach for the Pivot Park science park [...]
Sartorius Postpones Sale of Industrial Weighing Division
July 1, 2013
Goettingen, 3 – Sartorius, a leading international laboratory and pharmaceutical equipment provider, postponed the planned divestiture of its Industrial Weighing Division for the time being. While this division has attracted the wide interest of a number of investors, their investment decisions are being impacted by the current uncertain economic environment. “Interest in this business is [...]
Illumina Applies CE Mark to MiSeqDx™ Cystic Fibrosis System
July 1, 2013
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that it declared conformity with the requirements of the IVD Directive on June 26, 2013 and has applied the CE mark for the MiSeqDx Cystic Fibrosis System. The company is finalizing plans to commercialize the product in a number of European countries that require CE marking. The [...]

